TTX blocks baclofen-induced phase shifts of the mammalian circadian pacemaker in vitro

Citation
He. Bergeron et al., TTX blocks baclofen-induced phase shifts of the mammalian circadian pacemaker in vitro, BRAIN RES, 841(1-2), 1999, pp. 193-196
Citations number
19
Categorie Soggetti
Neurosciences & Behavoir
Journal title
BRAIN RESEARCH
ISSN journal
00068993 → ACNP
Volume
841
Issue
1-2
Year of publication
1999
Pages
193 - 196
Database
ISI
SICI code
0006-8993(19990911)841:1-2<193:TBBPSO>2.0.ZU;2-H
Abstract
The mammalian circadian pacemaker, located in the suprachiasmatic nucleus ( SCN), expresses 24-h rhythms when isolated in vitro. The GABA(A) agonist, m uscimol, induces phase advances during the mid-subjective day, while the GA BA(B) agonist, baclofen, induces both daytime phase advances and nighttime phase delays. Here, we present evidence that tetrodotoxin (TTX) completely blocks baclofen-induced phase shifts in vitro, but does not block in vitro phase advances induced by muscimol. These results suggest that GABA(A), but not GABA(B), receptors are located on SCN pacemaker cells. (C) 1999 Elsevi er Science B.V. All rights reserved.